Gene · 84148
Papers2,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Modeling-Based Machine Learning for Accurate Prediction of Gas Diffusivity and Permeability in Metal-Organic Frameworks. | ACS Mater Au | 2026 | 41550905 | PubTator, text mining | PubMed |
| Chemoresistance: The hidden barrier in cancer treatment. | Cancer Pathog Ther | 2026 | 41550358 | PubTator, text mining | PubMed |
| Narciclasine Alleviates Endothelial Inflammation and Atherosclerosis Initiation by Inhibiting Histone Lactylation-Mediated NF-κB Activation. | Inflammation | 2026 | 41543766 | PubTator, text mining | PubMed |
| Correction: Targeting KAT8 alleviates self-RNA-driven skin inflammation by modulating histone H4 lysine 16 acetylation in psoriasis. | Cell Death Differ | 2026 | 41535721 | PubTator, text mining | PubMed |
| Three-Dimensional Honeycomb-like Pb-MOF with Multiple Sites for Selective Gas Adsorption and Efficient CO2 Catalytic Conversion. | ACS Appl Mater Interfaces | 2026 | 41530970 | PubTator, text mining | PubMed |
| Vapor-Assisted Catalysis Enables Precise Construction of MOF-Derived Hierarchical Carbon Nanoarrays for High-Performance Supercapacitors. | Adv Sci (Weinh) | 2026 | 41521467 | PubTator, text mining | PubMed |
| Artificial Intelligence Empowered New Materials: Discovery, Synthesis, Prediction to Validation. | Nanomicro Lett | 2026 | 41513886 | PubTator, text mining | PubMed |
| MOF-Powered MicroRNA Catch for Ultrasensitive Breast-Cancer Screening. | Anal Chem | 2026 | 41493333 | PubTator, text mining | PubMed |
| BRD2 bridges TFIID and MOF-H4K16ac-containing nucleosomes to promote transcriptional initiation. | Mol Cell | 2026 | 41478281 | PubTator, text mining | PubMed |
| Adaptive Allocation of Monte Carlo Samples for Efficient, Multifidelity Computational Screening of Metal-Organic Frameworks. | J Chem Theory Comput | 2026 | 41400226 | PubTator, text mining | PubMed |
| The role of histone acetyltransferases in tumorigenesis and their therapeutic potential: A review. | Biochem Biophys Res Commun | 2026 | 41353920 | PubTator, text mining | PubMed |
| MOF-Derived Entropy-Stabilized Quinary Alloy@Cellulose Aerogel for Ultrafast Tetracycline Degradation via PMS Activation. | Small Methods | 2026 | 41351210 | PubTator, text mining | PubMed |
| The Genetic Basis of Neurological Disorders: Missense and Nonsense Variants in Three Pakistani Families With Syndromic Intellectual Disability. | Ann Hum Genet | 2026 | 41347281 | PubTator, text mining | PubMed |
| The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma. | Mol Cancer Ther | 2026 | 41294048 | PubTator, text mining | PubMed |
| Unravelling the Non-Concerted Proton Electron Transfer Mechanism of MOF-Derived Manganese Incorporated Cerium Oxide for Superior Oxygen Evolution Reaction: Experimental Evaluation and DFT Validation. | Small | 2026 | 41288133 | PubTator, text mining | PubMed |
| Metal-Organic Framework/Organocatalyst Combinations as Powerful Multicatalytic Systems for Aerobic Oxidations. | Angew Chem Int Ed Engl | 2026 | 41263182 | PubTator, text mining | PubMed |
| Integration of epigenetics into ecotoxicology: insights and fundamental research needs. | Biol Rev Camb Philos Soc | 2026 | 41242758 | PubTator, text mining | PubMed |
| Modifying MOF Electrocatalysts for Enhanced Oxygen and Hydrogen Evolution Reactions. | Small | 2026 | 41216770 | PubTator, text mining | PubMed |
| A Cu-Based Near-IR Active MOF with an Ion-Pair Guest Exhibiting Versatile and Selective Gas-Solid Reactivity. | Adv Mater | 2026 | 41147354 | PubTator, text mining | PubMed |
| Blocking Lysine Crotonylation and Aerobic Glycolysis as Targeting Strategy Against mpox Virus Replication. | Adv Sci (Weinh) | 2026 | 41144710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84148/papers?page=7